European Union - English - EMA (European Medicines Agency)

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older.the use of this vaccine should be in accordance with official recommendations.nuvaxovid xbb.1.5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older.the use of this vaccine should be in accordance with official recommendations.

Ireland - English - HPRA (Health Products Regulatory Authority)

cz vaccines s.a.u. - e.coli strain p4 (f6 adhesins), inactivated; e.coli strain p5 (f18 adhesins), inactivated; e. coli strain p6 (f4ac adhesins), inactivated; e. coli strain p9 (f18ac adhesins), inactivated; e.coli strain p10 (f5 + f41 adhesins), inactivated; ß toxoid of c. perfringens type c - emulsion for injection - . - escherichia + clostridium - pigs - immunological - inactivated vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

cz vaccines s.a.u. - purified protein derivative from culture of mycobacterium avium, subsp. avium strain d4 er - solution for injection - 25000 international unit(s)/millilitre - avian tuberculin ppd - cattle - immunological

Ireland - English - HPRA (Health Products Regulatory Authority)

cz vaccines s.a.u. - purified protein derivative from culture of mycobacterium bovis, strain an-5 - solution for injection - 2500 international units/dose - bovine tuberculin ppd - cattle - immunological

European Union - English - EMA (European Medicines Agency)

gsk vaccines s.r.l. - outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254), recombinant neisseria meningitidis group b fhbp fusion protein, recombinant neisseria meningitidis group b nada protein, recombinant neisseria meningitidis group b nhba fusion protein - meningitis, meningococcal - meningococcal vaccines - active immunisation against invasive disease caused by neisseria meningitidis serogroup-b strains.,

European Union - English - EMA (European Medicines Agency)

cz veterinaria s.a. - bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated] - immunologicals - sheep, cattle - sheepactive immunisation against bluetongue virus serotype 8 to prevent viraemia and to reduce clinical signs.onset of immunity: 20 days after second dose.duration of immunity: 1 year after second dose.cattleactive immunisation against bluetongue virus serotype 8 to prevent viraemia.onset of immunity: 31 days after second dose.duration of immunity: 1 year after second dose.

European Union - English - EMA (European Medicines Agency)

gsk vaccines s.r.l. - meningococcal group a, c, w-135 and y conjugate vaccine - immunization, meningitis, meningococcal - bacterial vaccines - prefilled syringe menveo is indicated for active immunisation of adolescents (from 11 years of age) and adults at risk of exposure to neisseria meningitidis groups a, c, w135 and y, to prevent invasive disease. the use of this vaccine should be in accordance with official recommendations. vials menveo is indicated for active immunisation of children (from two years of age), adolescents and adults at risk of exposure to neisseria meningitidis groups a, c, w135 and y, to prevent invasive disease. the use of this vaccine should be in accordance with official recommendations.,

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - hepatitis b; hepatitis a; immunization - vaccines - ambirix is for use in non-immune persons from one year up to and including 15 years of age for protection against hepatitis-a and hepatitis-b infection.protection against hepatitis-b infections may not be obtained until after the second dose.therefore:ambirix should be used only when there is a relatively low risk of hepatitis-b infection during the vaccination course;it is recommended that ambirix should be administered in settings where completion of the two-dose vaccination course can be assured.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

cz veterinaria s.a. - mycobacterium paratuberculosis - emulsion for injection - inactivated bacterial vaccine - goats, sheep

United Kingdom - English - VMD (Veterinary Medicines Directorate)

cz veterinaria s.a. - clostridium perfringens, escherichia coli - emulsion for injection - inactivated bacterial vaccine - pigs